Pharmaceuticals by one-year price change
How far the share price has moved over the last 52 weeks.
Alnylam Pharmaceuticals has the lowest figure of the 61 pharmaceuticals ranked by one-year price change, at -66.0%, followed by Ionis Pharmaceuticals (-63.6%) and Legend Biotech (-42.5%). Figures as of 18 Nov 2026, 16:31 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 61
- Lowest
- Alnylam Pharmaceuticals-66.0%
- Median
- +26.9%
- Combined market value
- AED 18.7T
- Countries
- 10
Market values as of .
All countries▾
All sectors▾
Pharmaceuticals▾
| # | Company | 1 year ↑ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | Alnylam PharmaceuticalsALNY · Health Care | -66.0% | AED 74.8B | AED 558.80 | 2.78% down | 66% down | ||
| 2 | Ionis PharmaceuticalsIONS · Health Care | -63.6% | AED 16.7B | AED 100.15 | 1.15% up | 64% down | ||
| 3 | Legend BiotechLEGN · Health Care | -42.5% | AED 11.6B | AED 59.73 | 0.96% up | 42% down | ||
| 4 | InsmedINSM · Health Care | -40.1% | AED 96.8B | AED 441.08 | 1.44% down | 40% down | ||
| 5 | Summit TherapeuticsSMMT · Health Care | -35.6% | AED 31.1B | AED 38.94 | 0.64% down | 36% down | ||
| 6 | ZoetisZTS · Health Care | -28.7% | AED 125.3B | AED 308.35 | 0.57% up | 29% down | ||
| 7 | ABIVAXABVX · Health Care | -27.3% | AED 27B | AED 308.50 | 2.31% up | 27% down | ||
| 8 | Madrigal PharmaceuticalsMDGL · Health Care | -24.0% | AED 34.8B | AED 1,499.89 | 3.22% down | 24% down | ||
| 9 | Cogent BiosciencesCOGT · Health Care | -20.3% | AED 18B | AED 103.71 | 1.40% up | 20% down | ||
| 10 | CytokineticsCYTK · Health Care | -20.3% | AED 26.2B | AED 187.96 | 0.91% down | 20% down | ||
| 11 | PTC TherapeuticsPTCT · Health Care | -20.2% | AED 18.5B | AED 221.15 | 0.24% down | 20% down | ||
| 12 | Abbott LaboratoriesABT · Health Care | -17.0% | AED 665B | AED 383.95 | 0.16% down | 17% down | ||
| 13 | Novo NordiskNVO · Health Care | -16.9% | AED 642B | AED 145.65 | 2.56% down | 17% down | ||
| 14 | Corcept TherapeuticsCORT · Health Care | -7.92% | AED 27.4B | AED 250.78 | 2.55% down | 8% down | ||
| 15 | Axsome TherapeuticsAXSM · Health Care | -7.37% | AED 25.8B | AED 489.65 | 1.93% down | 7% down | ||
| 16 | SanofiSNY · Health Care | -4.08% | AED 418.1B | AED 174.10 | 0.26% down | 4% down | ||
| 17 | GrifolsGRFS · Health Care | +1.41% | AED 21.3B | AED 31.27 | 1.33% down | 1% up | ||
| 18 | AstraZenecaAZN · Health Care | +2.41% | AED 1.02T | AED 658.04 | 1.70% down | 2% up | ||
| 19 | Dr. Reddy's LaboratoriesRDY · Health Care | +5.27% | AED 45.9B | AED 55.03 | 1.32% up | 5% up | ||
| 20 | GSKGSK · Health Care | +6.26% | AED 360.1B | AED 179.63 | 0.67% down | 6% up | ||
| 21 | Arrowhead PharmaceuticalsARWR · Health Care | +10.3% | AED 22.4B | AED 158.18 | 0.19% up | 10% up | ||
| 22 | BioMarin PharmaceuticalBMRN · Health Care | +11.3% | AED 42.8B | AED 221.09 | 2.89% up | 11% up | ||
| 23 | Rhythm PharmaceuticalsRYTM · Health Care | +13.0% | AED 29.8B | AED 430.54 | 0.53% up | 13% up | ||
| 24 | PfizerPFE · Health Care | +14.4% | AED 590.4B | AED 103.59 | 0.93% down | 14% up | ||
| 25 | BeOne MedicinesONC · Health Care | +16.8% | AED 169.5B | AED 1,484.10 | 2.22% down | 17% up | ||
| 26 | BridgeBio PharmaBBIO · Health Care | +17.2% | AED 55.6B | AED 285.32 | 1.16% up | 17% up | ||
| 27 | Elanco Animal HealthELAN · Health Care | +20.5% | AED 48.6B | AED 97.25 | 2.44% up | 20% up | ||
| 28 | United TherapeuticsUTHR · Health Care | +22.6% | AED 90.3B | AED 2,121.40 | 1.11% down | 23% up | ||
| 29 | NovartisNVS · Health Care | +25.0% | AED 1.08T | AED 573.18 | 1.92% down | 25% up | ||
| 30 | AbbVieABBV · Health Care | +25.7% | AED 1.88T | AED 1,060.87 | 1.35% down | 26% up | ||
| 31 | Vertex PharmaceuticalsVRTX · Health Care | +26.9% | AED 497.9B | AED 1,963.81 | 0.10% up | 27% up | ||
| 32 | Ascendis PharmaASND · Health Care | +27.8% | AED 65B | AED 991.05 | 0.49% down | 28% up | ||
| 33 | Mirum PharmaceuticalsMIRM · Health Care | +30.5% | AED 21.9B | AED 334.76 | 0.87% down | 31% up | ||
| 34 | Belite BioBLTE · Health Care | +31.0% | AED 23.7B | AED 583.96 | 0.81% up | 31% up | ||
| 35 | Bristol-Myers SquibbBMY · Health Care | +34.0% | AED 450.9B | AED 220.59 | 2.09% down | 34% up | ||
| 36 | Eli LillyLLY · Health Care | +34.9% | AED 4.55T | AED 5,108.03 | 1.75% down | 35% up | ||
| 37 | Regeneron PharmaceuticalsREGN · Health Care | +36.3% | AED 364B | AED 3,518.28 | 0.02% up | 36% up | ||
| 38 | Jazz PharmaceuticalsJAZZ · Health Care | +36.7% | AED 57.5B | AED 896.52 | 1.41% up | 37% up | ||
| 39 | Johnson & JohnsonJNJ · Health Care | +37.6% | AED 2.44T | AED 1,013.23 | 1.01% down | 38% up | ||
| 40 | Ligand PharmaceuticalsLGND · Health Care | +42.6% | AED 22.1B | AED 1,105.09 | 2.41% up | 43% up | ||
| 41 | Travere TherapeuticsTVTX · Health Care | +44.2% | AED 17.7B | AED 184.81 | 1.53% down | 44% up | ||
| 42 | Protagonist TherapeuticsPTGX · Health Care | +46.4% | AED 30B | AED 459.44 | 0.34% up | 46% up | ||
| 43 | Merck & CoMRK · Health Care | +50.8% | AED 1.26T | AED 513.10 | 2.55% down | 51% up | ||
| 44 | Takeda PharmaceuticalTAK · Health Care | +53.6% | AED 250.9B | AED 78.52 | 1.20% down | 54% up | ||
| 45 | AlkermesALKS · Health Care | +58.4% | AED 28.9B | AED 171.71 | 2.87% up | 58% up | ||
| 46 | Praxis Precision MedicinesPRAX · Health Care | +61.1% | AED 31.4B | AED 1,122.65 | 0.20% up | 61% up | ||
| 47 | GenmabGMAB · Health Care | +70.0% | AED 116.1B | AED 188.37 | 1.29% down | 70% up | ||
| 48 | Teva Pharmaceutical IndustriesTEVA · Health Care | +74.4% | AED 180.6B | AED 154.76 | 1.13% down | 74% up | ||
| 49 | Royalty PharmaRPRX · Health Care | +77.7% | AED 145.4B | AED 252.88 | 0.25% up | 78% up | ||
| 50 | Amneal PharmaceuticalsAMRX · Health Care | +83.3% | AED 27.6B | AED 79.29 | 2.23% up | 83% up | ||
| 51 | Edgewise TherapeuticsEWTX · Health Care | +88.2% | AED 16.6B | AED 151.20 | 2.07% down | 88% up | ||
| 52 | Roivant SciencesROIV · Health Care | +90.3% | AED 102.9B | AED 142.06 | 0.08% down | 90% up | ||
| 53 | ViatrisVTRS · Health Care | +95.5% | AED 87.1B | AED 75.93 | 1.10% up | 96% up | ||
| 54 | TG TherapeuticsTGTX · Health Care | +107% | AED 36.2B | AED 239.38 | 3.94% up | 107% up | ||
| 55 | Dianthus TherapeuticsDNTH · Health Care | +113% | AED 17.8B | AED 316.76 | 0.84% down | 113% up | ||
| 56 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | +126% | AED 27.7B | AED 352.72 | 0.98% up | 126% up | ||
| 57 | Definium TherapeuticsDFTX · Health Care | +169% | AED 14.4B | AED 105.15 | 2.55% down | 169% up | ||
| 58 | VeradermicsMANE · Health Care | +233% | AED 19.2B | AED 455.88 | 1.20% down | 233% up | ||
| 59 | Oruka TherapeuticsORKA · Health Care | +241% | AED 24.1B | AED 355.29 | 0.44% up | 241% up | ||
| 60 | Spyre TherapeuticsSYRE · Health Care | +286% | AED 33.3B | AED 350.44 | 1.72% up | 286% up | ||
| 61 | ErascaERAS · Health Care | +403% | AED 17B | AED 48.44 | 5.04% down | 403% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Sums are converted from US dollars at today's exchange rate (1 USD = 3.6726 AED).
Questions and answers
Which pharmaceuticals have the lowest one-year price change?
Alnylam Pharmaceuticals (-66.0%), Ionis Pharmaceuticals (-63.6%) and Legend Biotech (-42.5%) have the lowest one-year price change of the 61 pharmaceuticals ranked here as of 18 Nov 2026, 16:31 UTC.
How many pharmaceuticals are in this ranking?
61 are ranked by one-year price change.
What are these pharmaceuticals worth together?
The 61 pharmaceuticals ranked by one-year price change have a combined market value of AED 18.7T as of 18 Nov 2026, 16:31 UTC.
What does ranking by one-year price change measure?
How far the share price has moved over the last 52 weeks.
Learn how this ranking works
All markets guides →- 52-week high and low: what the range tells you
A stock's 52-week high and low are the highest and lowest prices it reached over the past year. Where today's price sits in that range, from 0% at the low to 100% at the high, shows how the past year has gone. Sources differ on whether they use closing or intraday prices, so the same stock's range can differ slightly.
- Drawdown and recovery: why a 50% fall needs a 100% gain
A drawdown is how far a price has fallen from its previous peak, as a percentage of that peak. Recovery needs a larger gain than the fall, because the gain starts from a smaller base: a 20% drop needs a 25% rise to get back, a 50% drop needs 100%, and a 75% drop needs 300%.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Pharmaceuticals by one-year price change”, data as of 18 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?by=year-change
Underlying data: Yahoo Finance; SEC EDGAR.